1. Home
  2. TYRA vs CRON Comparison

TYRA vs CRON Comparison

Compare TYRA & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

N/A

Current Price

$34.28

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo Cronos Group Inc.

CRON

Cronos Group Inc.

N/A

Current Price

$2.64

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TYRA
CRON
Founded
2018
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
TYRA
CRON
Price
$34.28
$2.64
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$44.63
N/A
AVG Volume (30 Days)
729.8K
1.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
6.79
157.89
EPS
N/A
N/A
Revenue
N/A
$117,615,000.00
Revenue This Year
N/A
$18.81
Revenue Next Year
N/A
$34.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
34.82
52 Week Low
$6.42
$1.60
52 Week High
$35.71
$3.43

Technical Indicators

Market Signals
Indicator
TYRA
CRON
Relative Strength Index (RSI) 64.83 46.27
Support Level $20.86 $2.44
Resistance Level N/A $2.77
Average True Range (ATR) 2.50 0.08
MACD 0.32 0.01
Stochastic Oscillator 84.16 21.70

Price Performance

Historical Comparison
TYRA
CRON

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About CRON Cronos Group Inc.

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Share on Social Networks: